Advanced search
Publication Cover
Journal of Asthma Volume 58, 2021 - Issue 6
Submit an article Journal homepage
158
Views
0
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Clinical profile of severe asthmatics receiving biological treatment: see behind the scenes

Ourania S. KotsiouDepartment of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Larissa, GreeceCorrespondence[email protected]
, MD, PhD,
Konstantinos I. GourgoulianisDepartment of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Larissa, Greece
, MD &
Zoe DaniilDepartment of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Larissa, Greece
, MD
Pages 805-807 | Received 10 Jan 2020, Accepted 29 Mar 2020, Published online: 14 Apr 2020

References

  • Müllerová H, Cockle SM, Gunsoy NB, Nelsen LM, Albers FC. Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study. J Asthma. 2019;24:1–16. doi:10.1080/02770903.2019.1708095.
  • Eileen W, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, Busby J, Jackson DJ, Pfeffer PE, Rhee CK, et al. Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR). Chest. 2019;157(4):790–804. doi:10.1016/j.chest.2019.10.053.
  • McClean KM, Kee F, Young IS, Elborn JS. Obesity and the lung: 1. Epidemiology. Thorax. 2008;63(7):649–654. doi:10.1136/thx.2007.086801.
  • Tashiro H, Shore SA. Obesity and severe asthma. Allergol Int. 2019;68(2):135–142. doi:10.1016/j.alit.2018.10.004.
  • Orfanos S, Jude J, Deeney BT, Cao G, Rastogi D, van Zee M, Pushkarsky I, Munoz HE, Damoiseaux R, Di Carlo D, et al. Obesity increases airway smooth muscle responses to contractile agonists. Am J Physiol Lung Cell Mol Physiol. 2018;315(5):L673–L681. doi:10.1152/ajplung.00459.2017.
  • O’Byrne P, Fabbri LM, Pavord ID, Papi A, Petruzzelli S, Lange P. Asthma progression and mortality: the role of inhaled corticosteroids. Eur Respir J. 2019;54(1):1900491. doi:10.1183/13993003.00491-2019.
  • Campo WP, Soto Campos G, Aparicio MB, Jorge AM, González Expósito HM, Quirce S, Dávila I. Severe asthma phenotypes in patients controlled with omalizumab: a real-world study. Respir Med. 2019;159:105804. doi:10.1016/j.rmed.2019.105804.
  • Sears MR. Lung function decline in asthma. Eur Respir J. 2007;30(3):411–413. doi:10.1183/09031936.00080007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.